Breaking Finance News

Danaher Corporation (NYSE:DHR) has been downgraded to Hold in a report by Zacks Investment Research today.

Just yesterday Danaher Corporation (NYSE:DHR) traded -0.54% lower at $77.37. Danaher Corporation’s 50-day average is $79.36 and its two hundred day average is $76.33. With the last stock price close up 1.14% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time period. 549,428 shares of the stock were exchanged, down from an avg. volume of 3,355,800

Zacks Investment Research has downgraded Danaher Corporation (NYSE:DHR) to Hold in a report released on Thursday September 29, 2016.

Previously on 09/27/2016, Zacks Investment Research reported on Danaher Corporation (NYSE:DHR) increased the target price from $0.00 to $86.00. At the time, this indicated a possible upside of 0.11%.

Performance Chart

Danaher Corporation (NYSE:DHR)

With a market capitalization of $0, Danaher Corporation has one year low of $61.60 and a 52 week high of $82.64 with a P/E ratio of 15.35 .

A total of 20 brokerages have issued a research note on the stock. 9 brokers rating the company a strong buy, six brokerages rating the stock a buy, eight analysts rating the stock a hold, 0 brokerages rating the stock a underperform, and finally 0 firms rating the company a sell with a 12-month price target of $104.22.

More About Danaher Corporation (NYSE:DHR)

Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services. Its Environmental segment products and services help protect the water supply, enhance the safety of personal data and improve business efficiencies. In the Life Sciences & Diagnostics segment, its diagnostics business offers analytical instruments, reagents, consumables, software and services. Its life sciences business offers research tools. Its Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. Its Industrial Technologies segment solutions help protect the world's food supply, improve packaging design and quality, and verify pharmaceutical dosages.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.